title: Prostate cancer--to screen, or not to screen, is that the question?
abstract: There continues to be controversy regarding serum Prostate-Specific Antigen (PSA) and prostate cancer screening. We anxiously await the results of two large prospective randomized clinical trials (Prostate, Lung, Colon, and Ovary-PCLO screening trial in the US and European Randomized Study of Screening for Prostate Cancer-ERSPC in Europe) assessing the benefits of prostate cancer screening. However the true question to answer may be which cancer to treat and when should we treat it.
authors.affiliation: Department of Urology and Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, USA. charles.rosser@urology.ufl.edu
authors.forename: Charles J
authors.initials: CJ
authors.lastname: Rosser
mesh_terms: D006801:Humans; D008297:Male; D008403:Mass Screening; D011471:Prostatic Neoplasms / Q000175:diagnosis*